Trial Profile
Phase I trial of NMIL-12-1 in patients with traumatic wounds.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Apr 2014
Price :
$35
*
At a glance
- Drugs NMIL 12 1 (Primary)
- Indications Wound infections
- Focus Adverse reactions
- Sponsors Neumedicines
- 30 Apr 2014 New trial record
- 29 Apr 2014 This trial has been recommended for funding by the US Department of Defense, according to a Neumedicines media release.